TRV GP, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Reported portfolio value by quarter (16 quarters reported)

$221M —

Q4 17 Q4 18 Q4 19 Q4 20 Q3 21

$221M in Q4 2017 → — now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2021. Activity is the change in share count since the prior quarter's filing.

Holding	% of portfolio	Activity	Shares	Value
0 0	NaN%	New	0	—

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

quarter ended September 30, 2021 · filed November 05, 2021

Company	Action	Shares changed	Value of change	% of portfolio
SB Sesen Bio, Inc.	Exited	−4,091,591	−$18.9M	—
0 0	New	+0	—	—

quarter ended June 30, 2021 · filed August 11, 2021

No position changes this quarter.

quarter ended March 31, 2021 · filed May 12, 2021

Company	Action	Shares changed	Value of change	% of portfolio
SB Sesen Bio, Inc.	New	+4,091,591	+$10.6M	100.0%
SB Sesen Bio, Inc.	Exited	−4,841,591	−$6.54M	—

quarter ended December 31, 2020 · filed February 16, 2021

No position changes this quarter.

quarter ended September 30, 2020 · filed November 06, 2020

Company	Action	Shares changed	Value of change	% of portfolio
CP Constellation Pharmaceuticals Inc.	Exited	−1,401,422	−$42.1M	—

quarter ended June 30, 2020 · filed August 10, 2020

Company	Action	Shares changed	Value of change	% of portfolio
CP Constellation Pharmaceuticals Inc.	Trimmed	−132,661	−$3.99M	92.4%

quarter ended March 31, 2020 · filed May 11, 2020

Company	Action	Shares changed	Value of change	% of portfolio
CP Constellation Pharmaceuticals Inc.	Trimmed	−1,500,000	−$47.1M	94.7%

quarter ended December 31, 2019 · filed February 05, 2020

Company	Action	Shares changed	Value of change	% of portfolio
Rhythm Pharmaceuticals, Inc.	Exited	−1,781,437	−$38.5M	—

Comments